Saturday, March 8, 2014

"Pay-to-Play" Meetings Help Get Drugs on Market

My opinion:  Frankly, I'm not surprised that this is going on.  Everybody knows that drug companies pay doctors to promote their products, but now it is apparent that they can use money to get past the FDA.  This may be even worse than before, as now drugs are on the market that are potentially very dangerous.  I am wondering what other methods there are to getting around obstacles.  I know that drug companies often withhold possibly bad experimental data, but perhaps there's more.  What if they pay lobbyists to pass more lenient drug laws?  Do you have any opinions or additions to this?  Feel free to comment.

Senators Allege That Drug Companies Paid To Help Get Approval For A Dangerous New Painkiller

FDA Commissioner Margaret Hamburg

Ever since a coalition of doctors came out against the controversial new painkiller Zohydro, health officials have been questioning how the drug got approved by the Food and Drug Administration in the first place. Now, two senators are questioning the ethics of a series of meetings between drug companies and federal regulators, MedPage Today reports.
Senators Joe Manchin (D-W.Va.) and David Vitter (R-La.) want answers about what they call "pay-to-play" meetings in which pharmaceutical manufacturers allegedly shelled out thousands of dollars to meet with FDA officials who oversee safety regulations on painkillers. The senators suggest these meetings might have helped Zohydro get approved by the FDA despite an advisory committee voting against it.


No comments:

Post a Comment